Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 53 No. 4 › β-Blockers for Autism—Help...
REVIEW ARTICLE

β-Blockers for Autism—Help or Hindrance?

Ahmed Naguy, Seshni Gourika Moodliar-Rensburg, Bibi Alamiri
Psychopharmacology Bulletin 53(4): 57-59, 2023/12/04; https://doi.org/10.64719/pb.4477

Abstract

A renewed interest in the use of β-blockers for neurodevelopmental disorders has recently resurfaced, notably as an addition to the limited psychopharmacological armamentarium of autism spectrum disorders (ASD). In this clinical perspective, authors decently argue this use could be advantageous and multi-folded for this population.

Keywords

akathisia, ASD, connectivity, EBAD, SAD, β-Blockers

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Ahmed Naguy, Seshni Gourika Moodliar-Rensburg, Bibi Alamiri. β-Blockers for Autism—Help or Hindrance?. Psychopharmacology Bulletin. 2023/12/04; 53(4):57-59. https://doi.org/10.64719/pb.4477